Identification of Clopidogrel CYP2C19 Metabolizer and Thienopyridine Treatment After an Acute Coronary Syndrome

NCT01390974 · clinicaltrials.gov ↗
COMPLETED
Status
270
Enrollment
OTHER
Sponsor class

Conditions

Sponsor

Assistance Publique - Hôpitaux de Paris

Collaborators